Canada markets close in 3 hours 17 minutes

Leap Therapeutics, Inc. (5MC.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.7600-0.1400 (-4.83%)
As of 08:11AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 109.46M
Enterprise Value 44.09M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)160.75
Price/Book (mrq)1.99
Enterprise Value/Revenue -62.52
Enterprise Value/EBITDA -0.54

Trading Information

Stock Price History

Beta (5Y Monthly) 0.59
52-Week Change 3-24.48%
S&P500 52-Week Change 325.38%
52 Week High 38.5000
52 Week Low 31.0300
50-Day Moving Average 32.5052
200-Day Moving Average 32.1890

Share Statistics

Avg Vol (3 month) 365
Avg Vol (10 day) 32
Shares Outstanding 538.26M
Implied Shares Outstanding 640.3M
Float 819.85M
% Held by Insiders 115.88%
% Held by Institutions 124.90%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 20.1:1
Last Split Date 3Jun 21, 2023

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-75.03%
Return on Equity (ttm)-136.82%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -85.92M
Net Income Avi to Common (ttm)-81.41M
Diluted EPS (ttm)-3.7000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)70.64M
Total Cash Per Share (mrq)2.76
Total Debt (mrq)262k
Total Debt/Equity (mrq)0.44%
Current Ratio (mrq)5.64
Book Value Per Share (mrq)2.35

Cash Flow Statement

Operating Cash Flow (ttm)-43.75M
Levered Free Cash Flow (ttm)-46.85M